Guillaume Freneuil – Vice President Intercontinental Operations, Consumer Healthcare Division, Ipsen
If we are investing right now in Algeria it is because we envisage further growth here to be able to serve patient needs
In Conversation
With our 29 certified R&D facilities in the country, our potential is great, and the already-pivotal pharmaceutical sector will only gain in importance
Having a holistic approach across healthy living, prevention, diagnostic, treatment and homecare and connecting it to IT technologies is Philips’ unique position
Part of our success is due to the GE group’s deep-rooted ties with Algeria.
Turkey is an important market for the strategic growth of GE and that GE is a crucial company for the development of healthcare in Turkey –…
Turkey's pharma sector is growing rapidly and it comes as no surprise that this attracts potential foreign partners
From the first day I started working for Merck, I’ve been impressed by the strong commitment of my team to make a positive difference to patients’…
The evolution [of the Algerian medtech sector] between 1997 and now has been very significant in terms of development and healthcare quality.
I think that Turkey is one of the world’s most unique countries. That established, I consider the biggest accomplishment to be ushering Mylan into the country…
We are committed to the localization movement in Turkey, and by next year, 90 percent of our portfolio will be Turkey-made
At the moment, Turkey is importing many high-value products, so the next step is to develop these products ourselves
We will strengthen our healthcare system by making primary healthcare services stronger and more organized
